Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine and Cytarabine for Relapsed or Refractory Acute Lymphocytic Leukemia

Clofarabine and cytarabine target different steps in DNA synthesis and replication, are synergistic in vivo, and have non-overlapping toxicities making this combination a potentially promising treatment for acute lymphocytic leukemia (ALL). Study goals were to: (1) evaluate the complete remission (C...

Full description

Saved in:
Bibliographic Details
Main Authors: Advani, Anjali S., Gundacker, Holly M., Sala-Torra, Olga, Radich, Jerald P., Lai, Raymond, Slovak, Marilyn L., Lancet, Jeffrey E., Coutre, Steve E., Stuart, Robert K., Mims, Martha P., Stiff, Patrick J., Appelbaum, Frederick R.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058291/
https://ncbi.nlm.nih.gov/pubmed/21113977
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items